Scheduling Chemotherapy: Catch 22 between Cell Kill and Resistance Evolution
From MaRDI portal
Publication:4489320
DOI10.1080/10273660008833047zbMATH Open0963.92023OpenAlexW1996366686MaRDI QIDQ4489320FDOQ4489320
Authors: Shea N. Gardner 
Publication date: 11 July 2000
Published in: Journal of Theoretical Medicine (Search for Journal in Brave)
Full work available at URL: https://eudml.org/doc/233461
Recommendations
- Evolution of resistance to anti-cancer therapy during general dosing schedules
- Conflicting objectives in chemotherapy with drug resistance
- scientific article; zbMATH DE number 819191
- scientific article; zbMATH DE number 1448576
- scientific article; zbMATH DE number 1114142
- Drug resistance in cancer chemotherapy as an optimal control problem
- Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies
- Chemotherapeutic Treatments with Time Increasing Mutation Rate to Drug Resistance
- Optimization of an \textit{in vitro} chemotherapy to avoid resistant tumours
chemotherapydrug kineticsresistance evolutiongene amplificationcontinuous infusioncell cycle phase-specific
Cited In (9)
- The mathematical modelling of adjuvant chemotherapy scheduling: incorporating the effects of protocol rest phases and pharmacokinetics
- Title not available (Why is that?)
- The application of mathematical modelling to aspects of adjuvant chemotherapy scheduling
- Evolution of resistance to anti-cancer therapy during general dosing schedules
- Dynamics of breast cancer under different rates of chemoradiotherapy
- Second-Order Effects of Chemotherapy Pharmacodynamics and Pharmacokinetics on Tumor Regression and Cachexia
- Title not available (Why is that?)
- Cell resensitization after delivery of a cycle-specific anticancer drug and effect of dose splitting: learning from tumour cords
- Reduction of cytotoxicity to normal tissues by new regimens of cell-cycle phase-specific drugs
This page was built for publication: Scheduling Chemotherapy: Catch 22 between Cell Kill and Resistance Evolution
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4489320)
